433806132024-01-012024-12-31433806132024-01-012024-12-311433806132024-01-012024-12-311433806132024-01-012024-12-312433806132024-01-012024-12-313433806132024-01-012024-12-311433806132024-01-012024-12-312433806132024-12-31433806132023-12-31fsa:ContributedCapitalMember433806132023-12-31fsa:RetainedEarningsMember433806132023-12-31433806132024-01-012024-12-31fsa:ContributedCapitalMember433806132024-01-012024-12-31fsa:RetainedEarningsMember433806132024-12-31fsa:ContributedCapitalMember433806132024-12-31fsa:RetainedEarningsMember433806132022-07-072023-12-31iso4217:DKKxbrli:pureThe Board of Directors and the Executive Board have today considered and approved the annual report of Agrobiomics ApS for the financial year 01.01.2024 - 31.12.2024.-1661730-1438078The annual report is presented in accordance with the Danish Financial Statements Act.44086323298468In our opinion, the financial statements give a true and fair view of the Entity’s financial position at 31.12.2024 and of the results of its operations for the financial year 01.01.2024 - 31.12.2024.68330We believe that the management commentary contains a fair review of the affairs and conditions referred to therein.-6077195-4736546We recommend the annual report for adoption at the Annual General Meeting.2398500Copenhagen355769170509Ananda Scherner-6193114-4907055Ejner Bech Jensen-1405966-1018986Theis Martin Malmborg-4787148-3888069Mikael Bechsgaard-4787148-3888069To the shareholders of Agrobiomics ApSWe have performed an extended review of the financial statements of Agrobiomics ApS for the ​financial year 01.01.2024 - 31.12.2024, which comprise the income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act. ​Based on our extended review, in our opinion, the financial statements give a true and fair view of the Entity’s ​financial position at 31.12.2024 and of the results of its operations for the financial year 01.01.2024 - 31.12.2024 in accordance with the Danish Financial Statements Act.1981670We conducted our extended review in accordance with the assurance engagement standard for small enterprises as issued by the Danish Business Authority and the standard on extended review of financial statements prepared in accordance with the Danish Financial Statements Act as issued by FSR - Danish Auditors. Our responsibilities under those standards and requirements are further described in the ”Auditor’s responsibilities for the extended review of the financial statements” section. We are independent of the Entity in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the evidence we have obtained is sufficient and appropriate to provide a basis for our conclusion.1981670The company has, with effect from the current financial year, opted to prepare its annual report in accordance with the provisions of the Danish Financial Statements Act concerning extended review. It should be emphasised that the comparative figures presented in the annual report have not been audited or subjected to an extended review in accordance with these provisions.1981670Management is responsible for the preparation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act, and for such internal control as Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, Management is responsible for assessing the Entity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern, and using the going concern basis of accounting unless Management either intends to liquidate the Entity or to cease operations, or has no realistic alternative but to do so.398933126512Our responsibility is to express a conclusion on the financial statements. This requires that we plan and perform procedures to obtain limited assurance about our conclusion on the financial statements and that we also perform specifically required supplementary procedures for the purpose of obtaining additional assurance about our conclusion. An extended review consists of making inquiries, primarily of Management and, if appropriate, of other entity personnel, performing analytical and the specifically required supplementary procedures as well as evaluating the evidence obtained. The procedures performed in an extended review are less in scope than in an audit, and accordingly we do not express an audit opinion on the financial statements.14059661018986Management is responsible for the management commentary. Our conclusion on the financial statements does not cover the management commentary, and we do not express any form of assurance conclusion thereon. In connection with our extended review of the financial statements our responsibility is to read the management commentary and, in doing so, consider whether the management commentary is materially inconsistent with the financial statements or our knowledge obtained in the extended review or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the management commentary provides the information required by relevant law and regulations.Based on the work we have performed, we conclude that the management commentary is in accordance with financial statements and has been prepared in accordance with the requirements in the relevant law and regulations. We did not identify any material misstatement of the management commentary.052618048991146024Copenhagen203797525979599Jonas Thøstesen Svensson221846517125623mne47824223828187125623State Authorised Public Accountant7881440000Leon Thomas Ravn Fagerlind21613960-3888069mne4991421692774-3848069State Authorised Public Accountant010168986Primary activitiesAgrobiomics ApS specializes in the research and development of agricultural solutions primarily aimed to increase crop yield and their resilience to environmental stresses, as well as activities that, in the opinion of the management, are related thereto.010168986Description of material changes in activities and financesThe company's research and development program consist of a series of ongoing projects aimed at developing, validating, and generating additional intellectual property rights for the company's technology. That includes, but is not limited to, new application methods, products and use guidelines on new crops and geographies across the Globe. The recorded research and development costs are calculated based on a principle of directly incurred personnel, material, and other direct costs, as well as allocated administrative costs. Management assesses that it is technically possible to complete the ongoing projects, and the company has the resources to complete them. Future economic benefits are expected when brining first products to market and traction with commercial partners is promising. 2919010918Events after the balance sheet dateNo events have occurred after the balance sheet date to this date, which would influence the evaluation of this annual report.304531513862This annual report has been presented in accordance with the provisions of the Danish Financial Statements Act governing reporting class B enterprises with addition of a few provisions for reporting class C.The accounting policies applied to these financial statements are consistent with those applied last year.356323279926Non-comparabilityThe comparative figures presented in the annual report cover an extended financial reporting period compared to the current financial year. The figures are not directly comparable. The current financial year covers the period from 01.01.2024 to 31.12.2024, while the previous financial year covered the period from 07.07.2022 to 31.12.2023.690044804706Recognition and measurementAssets are recognised in the balance sheet when it is probable as a result of a prior event that future economic benefits will flow to the Entity, and the value of the asset can be measured reliably. Liabilities are recognised in the balance sheet when the Entity has a legal or constructive obligation as a result of a prior event, and it is probable that future economic benefits will flow out of the Entity, and the value of the liability can be measured reliably. On initial recognition, assets and liabilities are measured at cost. Measurement subsequent to initial recognition is effected as described below for each financial statement item. Anticipated risks and losses that arise before the time of presentation of the annual report and that confirm or invalidate affairs and conditions existing at the balance sheet date are considered at recognition and measurement. Income is recognised in the income statement when earned, whereas costs are recognised by the amounts attributable to this financial year.69004410973692Public grantsPublic grants are recognised when a final commitment has been received from the grantor and it is probable that the conditions of the grant will be fulfilled. Grants are recognised as income in the income statement as earned. Grants awarded for acquisition of assets are recognised as deferred income in the balance sheet, which is taken to income on a straight-line basis over the useful life of the asset.223828187125623Gross profit or lossGross profit or loss comprises revenue, other operating income, cost of raw materials and consumables and external expenses.400005Other operating incomeOther operating income comprises income of a secondary nature as viewed in relation to the Entity’s primary activities.-3888069Cost of salesCost of sales comprises goods consumed in the financial year measured at cost, adjusted for normal inventory writedowns.Other external expensesOther external expenses include expenses relating to the Entity’s normal activities, including expenses for premises, stationery and office supplies, marketing costs, etc. This item also includes writedowns of receivables recognised in current assets.28147Staff costsStaff costs comprise salaries and wages, and social security contributions, pension contributions, etc . for entity staff.19961186Depreciation, amortisation and impairment lossesDepreciation, amortisation and impairment losses relating to property, plant and equipment comprise depreciation, amortisation and impairment losses for the financial year.19989333Other financial incomeOther financial income comprises interest income, payables and transactions in foreign currencies, amortisation of financial assets, and tax relief under the Danish Tax Prepayment Scheme etc.10667Other financial expensesOther financial expenses comprise interest expenses, payables and transactions in foreign currencies, amortisation of financial liabilities, and tax surcharge under the Danish Tax Prepayment Scheme etc.10519306Tax on profit/loss for the yearTax for the year, which consists of current tax for the year and changes in deferred tax, is recognised in the income statement by the portion attributable to the profit for the year and recognised directly in equity by the portion attributable to entries directly in equity.10529973Property, plant and equipmentLand and buildings, plant and machinery, and other fixtures and fittings, tools and equipment are ​measured at cost less accumulated depreciation and impairment losses. Land is not depreciated.​​Cost comprises the acquisition price, costs directly attributable to the acquisition and preparation costs of the asset until the time when it is ready to be put into operation. ​​The basis of depreciation is cost less estimated residual value after the end of useful life. Straight-line depreciation is made on the basis of the following estimated useful lives of the assets:Useful life Other fixtures and fittings, tools and equipment5Estimated useful lives and residual values are reassessed annually. ​​Items of property, plant and equipment are written down to the lower of recoverable amount and carrying ​amount.191315191315ReceivablesReceivables are measured at amortised cost, usually equalling nominal value less writedowns for bad and doubtful debts.-4787148Tax payable or receivableCurrent tax payable or receivable is recognised in the balance sheet, stated as tax computed on this year's taxable income, adjusted for prepaid tax.PrepaymentsPrepayments comprise incurred costs relating to subsequent financial years. Prepayments are measured at cost.78814CashCash comprises cash in hand and bank deposits.21613960Other financial liabilitiesOther financial liabilities are measured at amortised cost, which usually corresponds to nominal value.true1 Staff costs2024 DKK2022/23 DKKWages and salaries4,253,6003,157,101Pension costs102,000111,301Other social security costs53,03230,0664,408,6323,298,468Average number of full-time employees75Grundlag for konklusion7Konklusion2 Depreciation, amortisation and impairment losses2024 DKK2022/23 DKKDepreciation of property, plant and equipment6,83306,83302025-06-253 Other financial income 2024 DKK2022/23 DKKOther interest income239,8500239,85002025-06-254 Other financial expenses2024 DKK2022/23 DKKOther interest expenses350,375170,431Exchange rate adjustments5,39478355,769170,509true5 Tax on profit/loss for the year2024 DKK2022/23 DKKCurrent tax(1,405,966)(1,018,986)(1,405,966)(1,018,986)2022-07-076 Property, plant and equipmentOther fixtures and fittings, tools and equipment​DKKAdditions205,000Cost end of year205,000Depreciation for the year(6,833)Depreciation and impairment losses end of year(6,833)Carrying amount end of year198,1672023-12-3133963556København S23006WeidekampsgadeDeloitte Statsautoriseret RevisionspartnerselskabKøbenhavnKøbenhavn N2200Regnskabsklasse BErklæring om udvidet gennemgang2024-12-312024-01-013Ole Maaløes VejAgrobiomics ApS43380613339635562300 København SWeidekampsgade 6Deloitte Statsautoriseret RevisionspartnerselskabÅrsrapport2025-06-25Ananda Scherner